Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Rheumatic Disease ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Chapter 23. Antiphospholipid antibody syndrome.in: Imboden J.B. Hellmann D.B. Stone J.H. Current diagnosis & treatment: rheumatology. The McGraw-Hill Companies, New York2013 (Available at:) (Accessed May 21, 2017)
- Neurological manifestations of antiphospholipid syndrome.Eur J Clin Invest. 2010; 40: 350-359
- The antiphospholipid syndrome.N Engl J Med. 2002; 346: 752-763
- Neurologic manifestations of the antiphospholipid syndrome.Curr Rheumatol Rep. 2001; 3: 286-292
- Neurologic manifestations of the antiphospholipid syndrome.Curr Rheumatol Rep. 2007; 9: 109-115
- Autoantibodies as biomarkers for the prediction of neuropsychiatric events in systemic lupus erythematosus.Ann Rheum Dis. 2011; 70: 1726-1732
- Stroke in systemic lupus erythematosus and antiphospholipid syndrome: risk factors, clinical manifestations, neuroimaging, and treatment.Lupus. 2017; 26: 529-536
- Migraine, memory loss, and “multiple sclerosis.” Neurological features of the antiphospholipid (Hughes’) syndrome.Postgrad Med J. 2003; 79: 81-83
- The estimated frequency of antiphospholipid antibodies in young adults with cerebrovascular events: a systematic review.Ann Rheum Dis. 2015; 74: 2028-2033
- The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level.Ann Intern Med. 1987; 106: 524-531
- Impact of hypertension and hyperhomocysteinemia on arterial thrombosis in primary antiphospholipid syndrome.Lupus. 2007; 16: 782-787
- Sneddon syndrome with or without antiphospholipid antibodies. A comparative study in 46 patients.Medicine (Baltimore). 1999; 78: 209-219
- Cardiac manifestations in the antiphospholipid syndrome.Rheum Dis Clin North Am. 2006; 32: 491-507
- Non-stroke central neurologic manifestations in antiphospholipid syndrome.Curr Rheumatol Rep. 2016; 18: 11
- Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.Arch Intern Med. 2006; 166: 2278-2284
- Cognitive disorders and antiphospholipid antibodies.Autoimmun Rev. 2016; 15: 1193-1198
- Neuropsychological deficits associated with antiphospholipid antibodies.J Clin Exp Neuropsychol. 1999; 21: 251-264
- A longitudinal study of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus.Arthritis Rheum. 1999; 42: 735-741
- A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus.Arthritis Rheum. 1999; 42: 728-734
- Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients.Clin Exp Rheumatol. 2014; 32: 34-40
- Functional magnetic resonance imaging of working memory and executive dysfunction in systemic lupus erythematosus and antiphospholipid antibody-positive patients.Arthritis Care Res. 2016; 68: 1655-1663
- Neurological antiphospholipid syndrome: clinical, neuroimaging, and pathological characteristics.J Neurol Sci. 2014; 346: 138-144
- Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.Arthritis Rheum. 2002; 46: 1019-1027
- Prevalence and clinical features of dementia associated with the antiphospholipid syndrome and circulating anticoagulants.J Neurol Sci. 2002; 203–204: 81-84
- Reversible dementia and chorea in a young woman with the lupus anticoagulant.Neurology. 1996; 46: 1599-1603
- Cerebral venous sinus thrombosis as an initial manifestation of primary antiphospholipid syndrome.Am J Emerg Med. 2013; 31: 888.e1-3
- The Euro-Phospholipid project: epidemiology of the antiphospholipid syndrome in Europe.Lupus. 2009; 18: 889-893
- Features associated with epilepsy in the antiphospholipid syndrome.J Rheumatol. 2004; 31: 1344-1348
- Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus.Arthritis Rheum. 1994; 37: 568-571
- Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome).Lupus. 2006; 15: 191-197
- Epileptic seizures in systemic lupus erythematosus.Neurology. 2004; 63: 1808-1812
- Study of antiphospholipid antibodies in patients treated with antiepileptic drugs.Neurologica. 2001; 16: 7-10
- Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies.Lupus. 2003; 12: 514-517
- Antiphospholipid and antinuclear antibodies in patients with epilepsy or new-onset seizure disorders.Am J Med. 2000; 109: 712-717
- Seizures in primary antiphospholipid syndrome: the relevance of smoking to stroke.Clin Dev Immunol. 2012; 2012: 981519
- Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes.Lupus. 1999; 8: 127-133
- Chorea in primary antiphospholipid syndrome is associated with rheumatic fever.Rheumatol Int. 2012; 32: 2857-2861
- Chorea in the antiphospholipid syndrome. Clinical, radiologic, and immunologic characteristics of 50 patients from our clinics and the recent literature.Medicine (Baltimore). 1997; 76: 203-212
- CNS dysfunction in the antiphospholipid syndrome.Lupus. 2003; 12: 903-907
- Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study.Neurology. 1998; 50: 1433-1440
- Migraine in patients with stroke and antiphospholipid antibodies.Headache. 1993; 33: 421-426
- Cerebral manifestations in the antiphospholipid (Hughes) syndrome.Rheum Dis Clin North Am. 2006; 32: 465-490
- Systemic autoimmune features and multiple sclerosis: a 5-year follow-up study.Arch Neurol. 1998; 55: 517-521
- A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?.Ann Neurol. 1998; 44: 629-634
- Can neurologic manifestations of Hughes (antiphospholipid) syndrome be distinguished from multiple sclerosis? Analysis of 27 patients and review of the literature.Medicine (Baltimore). 2000; 79: 57-68
- Current treatment of antiphospholipid syndrome: lights and shadows.Nat Rev Rheumatol. 2015; 11: 586-596
- Transverse myelopathy in systemic lupus erythematosus: an analysis of 14 cases and review of the literature.Ann Rheum Dis. 2000; 59: 120-124
- Acute optic neuropathy and transverse myelopathy in patients with antiphospholipid antibody syndrome: favorable outcome after treatment with anticoagulants and glucocorticoids.Lupus. 2000; 9: 307-310
- High association of anticardiolipin antibodies with psychosis.J Clin Psychiatry. 1998; 59: 20-23
- Antiphospholipid antibodies in blood and cerebrospinal fluids of patients with psychosis.J Neuroimmunol. 2007; 190: 151-156
- Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients.Biol Psychiatry. 1991; 30: 731-735
- A patient with bipolar disorder and antiphospholipid syndrome.J Geriatr Psychiatry Neurol. 2012; 25: 26-28
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).J Thromb Haemost. 2006; 4: 295-306
- Laboratory diagnosis and management challenges in the antiphospholipid syndrome.Lupus. 2006; 15: 172-178
- Cognitive dysfunction and white matter abnormalities in antiphospholipid syndrome.Pathophysiology. 2011; 18: 93-102
- Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus.Am J Med. 1995; 99: 397-401
- Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases.Neurology. 1990; 40: 1181-1189
- Antiphospholipid syndrome presenting as progressive neuropsychiatric disorders: two case reports.Neuropsychiatr Dis Treat. 2013; 9: 739-742
- Anticoagulation for noncardiac indications in neurologic patients: comparative use of non-vitamin K oral anticoagulants, low-molecular-weight heparins, and warfarin.Curr Treat Options Neurol. 2014; 16: 309
- Management of antiphospholipid antibody syndrome: a systematic review.JAMA. 2006; 295: 1050-1057
- A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome.N Engl J Med. 2003; 349: 1133-1138
- EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.Ann Rheum Dis. 2008; 67: 195-205
- Dramatic response of severe headaches to anticoagulation in a patient with antiphospholipid syndrome.J Clin Rheumatol. 2007; 13: 173-174
- Obsessive-compulsive behavior as presenting symptom of primary antiphospholipid syndrome.Psychosom Med. 2013; 75: 326-330
- Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies.J Rheumatol. 2004; 31: 280-285
- Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report.Lupus. 2003; 12: 518-523
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs.Ann Rheum Dis. 2010; 69: 2074-2082
- Complex movement disorders in primary antiphospholipid syndrome: a case report.J Neurol Sci. 2009; 281: 101-103
- Early neuropsychiatric involvement in antiphospholipid syndrome.Gen Hosp Psychiatry. 2012; 34: 579.e1-3
Article info
Footnotes
Disclosure Statement: No disclosures.
Identification
Copyright
© 2017 Elsevier Inc. All rights reserved.
